Dementia study to trial Chinese medicine | SBS News

A herbal medicine that appears to have shown promise in treating one type of dementia in China is entering its largest clinical trial in Australia. More than 200 people living with the condition are being recruited for a trial with the Sydney-based National Institute of Complementary Medicine after a deal was struck with one of China’s largest drug manufacturers. Rachael Hocking reports. Experts say vascular dementia is the second most common type of dementia affecting more than 340,000 Australians living with the condition.

Source: Dementia study to trial Chinese medicine | SBS News